72P - The different prognostic impact of age according to individual molecular subtypes in breast cancer
|Date||18 December 2016|
|Event||ESMO Asia 2016 Congress|
|Topics|| Breast Cancer, Early Stage
Cancer in Young Adults
|Presenter||Yong Hwa Eom|
|Citation||Annals of Oncology (2016) 27 (suppl_9): ix19-ix29. 10.1093/annonc/mdw575|
Y.H. Eom, B.J. Song, B.J. Chae, S.H. Yoo
Young age at diagnosis has been considered as a poor prognostic factor in breast cancer. But, it is unjust to consider that young age is the independent poor prognostic factor for all breast cancer. We analyzed the different prognostic impact of age according to molecular subtypes.
Our study retrieved data from 1,410 patients with primary breast cancer who underwent surgery and the adjuvant treatment between 2007 and 2011. The association of age and molecular subtypes with recurrence free survival(RFS) and disease specific survival(DSS) was assessed using Kaplan-Meier analysis, univariate and multivariate analysis.
Age at diagnosis of breast cancer had different role for prognosis according to molecular subtypes. Age itself is not the independent prognostic factor. Age
Clinical trial indentification
Legal entity responsible for the study
All authors have declared no conflicts of interest.